Corporate News     25-May-22
Natco Pharma update on lawsuit for Glatiramer Acetate Injection
Natco Pharma announced that Johnson & Johnson's and Momenta Pharmaceuticals has filed a lawsuit against NATCO and its marketing partner Mylan Pharmaceuticals Inc. (Mylan) & others alleging infringement of two old Patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate Injection.

This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner, Mylan believe this is a meritless suit for a product that has been in the market for more than 5 years. Mylan and NATCO will strongly defend against this suit.

Previous News
  Natco Pharma fixes record date for 3rd interim dividend
 ( Market Beat - Reports 14-Feb-24   15:11 )
  Natco Pharma Ltd soars 3.1%, gains for fifth straight session
 ( Hot Pursuit - 19-Feb-24   13:00 )
  Natco Pharma to table results
 ( Corporate News - 27-Jul-24   10:19 )
  Natco Pharma reports consolidated net profit of Rs 275.80 crore in the March 2023 quarter
 ( Results - Announcements 29-May-23   15:39 )
  Natco Pharma Ltd spurts 1.25%, up for third straight session
 ( Hot Pursuit - 23-Aug-24   13:05 )
  Natco Pharma fixes record date for interim dividend
 ( Market Beat - Reports 15-Nov-23   11:36 )
  Natco Pharma Ltd spurts 1.44%, gains for five straight sessions
 ( Hot Pursuit - 09-Aug-23   13:00 )
  Natco Pharma to hold board meeting
 ( Corporate News - 09-May-24   16:50 )
  Natco Pharma
 ( Results - Analysis 30-May-23   11:27 )
  Natco Pharma's Vizag unit completes USFDA inspection
 ( Corporate News - 04-Feb-23   11:07 )
  Natco Pharma invests US$2 million in Cellogen Therapeutics
 ( Hot Pursuit - 18-Jan-24   10:49 )
Other Stories
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
Back Top